Two Sigma Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.17M | Sell |
9,000
-600
| -6% | -$145K | ﹤0.01% | 1083 |
|
2025
Q1 | $2.34M | Sell |
9,600
-500
| -5% | -$122K | 0.01% | 1096 |
|
2024
Q4 | $3.32M | Sell |
10,100
-800
| -7% | -$263K | 0.01% | 887 |
|
2024
Q3 | $3.65M | Sell |
10,900
-3,968
| -27% | -$1.33M | 0.01% | 821 |
|
2024
Q2 | $4.06M | Sell |
14,868
-2,300
| -13% | -$628K | 0.01% | 858 |
|
2024
Q1 | $5.94M | Sell |
17,168
-3,800
| -18% | -$1.31M | 0.01% | 711 |
|
2023
Q4 | $6.77M | Sell |
20,968
-31,800
| -60% | -$10.3M | 0.02% | 687 |
|
2023
Q3 | $18.9M | Buy |
52,768
+700
| +1% | +$251K | 0.05% | 323 |
|
2023
Q2 | $19.7M | Buy |
52,068
+3,200
| +7% | +$1.21M | 0.05% | 308 |
|
2023
Q1 | $23.4M | Sell |
48,868
-14,400
| -23% | -$6.9M | 0.06% | 288 |
|
2022
Q4 | $26.6M | Buy |
63,268
+11,200
| +22% | +$4.71M | 0.07% | 260 |
|
2022
Q3 | $21.7M | Buy |
52,068
+6,900
| +15% | +$2.88M | 0.06% | 303 |
|
2022
Q2 | $22.4M | Buy |
45,168
+9,800
| +28% | +$4.85M | 0.06% | 301 |
|
2022
Q1 | $19.9M | Buy |
35,368
+18,600
| +111% | +$10.5M | 0.05% | 322 |
|
2021
Q4 | $12.7M | Buy |
16,768
+15,200
| +969% | +$11.5M | 0.03% | 432 |
|
2021
Q3 | $1.17M | Buy |
1,568
+1,200
| +326% | +$895K | ﹤0.01% | 1543 |
|
2021
Q2 | $237K | Sell |
368
-500
| -58% | -$322K | ﹤0.01% | 2223 |
|
2021
Q1 | $496K | Buy |
+868
| New | +$496K | ﹤0.01% | 2016 |
|
2020
Q3 | – | Sell |
-20,765
| Closed | -$9.38M | – | 2407 |
|
2020
Q2 | $9.38M | Sell |
20,765
-29,200
| -58% | -$13.2M | 0.03% | 579 |
|
2020
Q1 | $17.5M | Sell |
49,965
-50,500
| -50% | -$17.7M | 0.07% | 315 |
|
2019
Q4 | $37.2M | Buy |
100,465
+1,300
| +1% | +$481K | 0.09% | 259 |
|
2019
Q3 | $33M | Buy |
99,165
+33,900
| +52% | +$11.3M | 0.08% | 281 |
|
2019
Q2 | $20.4M | Sell |
65,265
-5,100
| -7% | -$1.59M | 0.05% | 397 |
|
2019
Q1 | $21.5M | Buy |
70,365
+62,500
| +795% | +$19.1M | 0.05% | 393 |
|
2018
Q4 | $1.83M | Sell |
7,865
-2,900
| -27% | -$673K | 0.01% | 1211 |
|
2018
Q3 | $3.37M | Buy |
10,765
+700
| +7% | +$219K | 0.01% | 992 |
|
2018
Q2 | $2.9M | Buy |
10,065
+1,500
| +18% | +$433K | 0.01% | 1125 |
|
2018
Q1 | $2.14M | Sell |
8,565
-13,800
| -62% | -$3.45M | 0.01% | 1218 |
|
2017
Q4 | $5.34M | Buy |
22,365
+18,800
| +527% | +$4.49M | 0.01% | 824 |
|
2017
Q3 | $792K | Buy |
3,565
+2,200
| +161% | +$489K | ﹤0.01% | 1564 |
|
2017
Q2 | $309K | Sell |
1,365
-1,000
| -42% | -$226K | ﹤0.01% | 1982 |
|
2017
Q1 | $471K | Sell |
2,365
-800
| -25% | -$159K | ﹤0.01% | 1922 |
|
2016
Q4 | $577K | Sell |
3,165
-1,200
| -27% | -$219K | ﹤0.01% | 1798 |
|
2016
Q3 | $715K | Sell |
4,365
-5,200
| -54% | -$852K | ﹤0.01% | 1506 |
|
2016
Q2 | $1.37M | Sell |
9,565
-25,500
| -73% | -$3.65M | 0.01% | 1022 |
|
2016
Q1 | $4.79M | Sell |
35,065
-2,700
| -7% | -$369K | 0.03% | 513 |
|
2015
Q4 | $5.24M | Sell |
37,765
-28,100
| -43% | -$3.9M | 0.03% | 435 |
|
2015
Q3 | $8.87M | Sell |
65,865
-17,200
| -21% | -$2.32M | 0.06% | 353 |
|
2015
Q2 | $12.5M | Buy |
83,065
+800
| +1% | +$120K | 0.09% | 252 |
|
2015
Q1 | $11.1M | Buy |
82,265
+57,800
| +236% | +$7.81M | 0.08% | 290 |
|
2014
Q4 | $2.95M | Buy |
24,465
+1,000
| +4% | +$121K | 0.02% | 629 |
|
2014
Q3 | $2.66M | Sell |
23,465
-6,300
| -21% | -$714K | 0.02% | 624 |
|
2014
Q2 | $3.56M | Buy |
29,765
+21,200
| +248% | +$2.54M | 0.03% | 521 |
|
2014
Q1 | $1.1M | Sell |
8,565
-700
| -8% | -$89.7K | 0.01% | 868 |
|
2013
Q4 | $1.15M | Sell |
9,265
-12,200
| -57% | -$1.51M | 0.01% | 839 |
|
2013
Q3 | $2.52M | Sell |
21,465
-13,083
| -38% | -$1.54M | 0.03% | 440 |
|
2013
Q2 | $3.88M | Buy |
+34,548
| New | +$3.88M | 0.06% | 283 |
|